News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's 3/28/2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos 3/28/2017
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor 3/28/2017
Elon Musk Launches Neuroscience Startup to Plug AI Into Your Brain 3/28/2017
Nearly 500 Amgen (AMGN) Staffers to be Reassigned, Relocated or Laid Off in Restructuring 3/27/2017
Media Mogul Rupert Murdoch Dumps $125 Million Theranos Stake for $1 3/27/2017
These Two Drugmakers Have Even More Debt Than Valeant (VRX) 3/27/2017
Drug Giant Amgen (AMGN) to Create Hundreds of New Jobs in Florida 3/27/2017
Former Baxalta (BXLT) CEO to Helm Struggling Alexion (ALXN) 3/27/2017
Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued 3/27/2017
Google (GOOG)'s Verily Employees Make Themselves at Home at Onyx (AMGN)'s Former HQ 3/24/2017
Despite Recent Layoffs, Eli Lilly (LLY) to Invest $850 Million in U.S. Operations 3/24/2017
Bay Area's Ultragenyx (RARE) Tanks as Seizure Drug Flunks Phase II Test 3/24/2017
Boston's Paratek Pharma (PRTK) Expands Pennsylvania Operations With 30 Employees, Can Accommodate 100 3/24/2017
5 Biotechs That Have Major Catalysts Coming in the Next 6 to 9 Months 3/24/2017
Why Struggling Bristol-Myers Squibb (BMY) Could Take Out This Danish Biotech in Major €500M Deal 3/23/2017
How Biogen (BIIB) Spinoff Bioverativ (BIVVV) and Its Hemophilia Med Could Make This Biotech Bleed 3/23/2017
UCSF Heart Doctor Wary of Amgen (AMGN)-Paid Repatha Study 3/23/2017
Filing Shows Money Woes May Force NeuralStem to Halt Trials, Cease Operations or File for Bankruptcy 3/23/2017
Reverse Merger With Dare Bioscience Gives Cerulean (CERU) Execs a Parting Gift—Bonuses 3/23/2017
How This Drug Candidate Could be a Winner in Gilead (GILD)'s Pipeline 3/23/2017
Intellia’s CEO Has Cambridge-Based Company Moving Forward on Positive in vivo Data 3/22/2017
Heat Biologics (HTBX) Rockets as Lung Cancer Med Hits Mid-Stage Goals 3/22/2017
Filings Reveal Alnylam (ALNY) CEO's Pay Dropped Almost 80% in 2016 3/22/2017
Cerulean (CERU) to Slash More Than Half of Its Remaining Staff, Merge With SoCal Biotech 3/21/2017
Trump Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals 3/21/2017
Trump's Expected Policy Changes Have Propelled These 2 Biotechs to New Highs 3/20/2017
Why This Biotech Says It's Close to Curing the Type of Cancer That Killed Steve Jobs 3/20/2017
Crippled Bay Area Pharma Threshold (THLD) Rockets on Reverse Merger Deal With Molecular Templates 3/20/2017
The Hype Behind Massachusetts Biotech Corbus (CRBP)' Sole Pipeline Drug 3/20/2017
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion 3/20/2017
How 3 Laid Off Employees Turned Pfizer (PFE)'s Discarded Compounds Into Novartis AG (NVS) Gold 3/17/2017
World's Smartest Billionaire Upped Position in This Bay Area Biotech 3/17/2017
Major Reorganization to Hit the NIH, Deep Cuts to Affect Thousands Under Trump Budget Plan 3/17/2017
Lawmakers Question the FDA's "Unusual" Approval of Marathon Pharma's Controversial Old DMD Drug 3/16/2017
AstraZeneca PLC (AZN) Steals Tesaro (TSRO)'s PARP Thunder With Phase III Ovarian Cancer Data 3/16/2017
Bernie Sanders: Trump Must Stop Sanofi (SNY)'s Exclusive Zika Deal 3/15/2017
What a Gilead (GILD)-Incyte (INCY) Marriage Would Look Like 3/15/2017
GlaxoSmithKline (GSK)'s First Woman CEO Will Get a Smaller Paycheck Than (Male) Predecessor 3/15/2017
It's Official: Trump Nominates Scott Gottlieb for Top FDA Job 3/14/2017
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials 3/14/2017
Why an Acquisition of This CAR-T Biotech Makes Sense 3/14/2017
Shakeup at Intrexon (XON) as a Subsidiary is Created and an Ex-Pfizer (PFE) Exec Exits in Reorg 3/14/2017
Ackman Is Finally Done With Valeant (VRX), Takes $2.8 Billion Loss and Will Step Down From Board 3/14/2017
A Win for venBio as Judge Hits Pause on Immunomedics (IMMU)'s $2 Billion Deal With Seattle Genetics (SGEN) 3/13/2017
Boston Scientific (BSX) Commits to 10 More Years in SoCal Space, Plans to Hire 3/10/2017
Trump's Pick for New FDA Head Getting Down to the Wire 3/10/2017
Painful Setbacks Lead Bristol-Myers Squibb (BMY) to Bring in a New R&D Chief 3/10/2017
C-Suite Shakeup: Novogen (NVGN) CEO North America, CSO and CFO Exit in Reorg 3/10/2017
Pfizer (PFE) Eyes $100 Million Expansion, New Jobs in North Carolina 3/10/2017
Oscar Winner Turned Pharma CEO: We’ll Prevent Genital Herpes 3/10/2017
Retrophin (RTRX) to Close Down Cambridge Operations, Cut Jobs in Consolidation Move 3/10/2017
Merck KGaA (MKGAF.PK) in Deep Talks to Sell Biosimilars Unit 3/10/2017
AstraZeneca PLC (AZN) Had 'Fake Doctor' Under Payroll in Australia 3/9/2017
Backed by Google (GOOG), Cambridge's Spero Nabs $51.7 Million Series C 3/8/2017
NantHealth (NH) Founder Patrick Soon-Shiong Calls Report on Fund Diversion 'Maliciously False' 3/8/2017
World's Richest Doctor Accused of Diverting Donations Back to His Own Companies 3/8/2017
Why Pharma Giant AstraZeneca PLC (AZN)'s Market Value Gained $3.8 Billion Last Month 3/7/2017
Amgen (AMGN) Files Trade Secret Action Against Bay Area's Coherus 3/7/2017
2 Tempting Biotech Stocks to Avoid Like Mad 3/7/2017
Why Ex-Mayor Peterson is Stepping Down From Eli Lilly (LLY) After 7 Years On the Job 3/7/2017
Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data 3/6/2017
Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina 3/6/2017
Why This Alzheimer's Biotech May Not Live to See 2020 3/6/2017
Following Up on Bristol-Myers Squibb (BMY)'s Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site 3/6/2017
Short Sellers Load Up on Pfizer (PFE) After Buyout Rumors 3/6/2017
Juno (JUNO) Finally Drops Problem CAR-T Drug That Caused Deaths 3/3/2017
10 Biotechs With an Orphan Drug in Late-Stage Pipeline 3/3/2017
Novartis AG (NVS) Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year 3/3/2017
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars 3/3/2017
Backed by Amazon (AMZN) and Big Names Like Bristol-Myers Squibb (BMY), Celgene (CELG) and Merck & Co. (MRK), Bay Area's GRAIL Banks $900 Million 3/3/2017
9 Massachusetts Biotechs Facing Major FDA Decisions This Year 3/3/2017
Kite Pharma (KITE)'s CAR-T Blood Cancer Candidate Succeeds in Major Study 3/2/2017
6 Biotechs Facing Key FDA Decisions in March 3/2/2017
Why a Double-Digit Job Growth is Set to Hit This Biotech Hub 3/2/2017
Pfizer (PFE)'s Kansas Plant is 'Out of Control' and Puts Patients at Risk, Says the FDA 3/2/2017
Avoid These 3 Biotech Stocks Like the Plague 3/2/2017
Trump Takes Another Shot at the FDA's 'Slow And Burdensome' Approval Process 3/1/2017
Veloxis Pharma (VELO) to Shut Down New Jersey Office, Moving All Operations to North Carolina 3/1/2017
Exclusive: Janssen Pharmaceutical Just Came Clean on Drug Pricing Data 3/1/2017
Perrigo (PRGO) Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen (AMGN) 3/1/2017
The 5 Drug Giants That Could Snap Up a Struggling Bristol-Myers Squibb (BMY) 3/1/2017
Merck & Co. (MRK), Eli Lilly (LLY) Failure Puts Alzheimer's Drug Development Spotlight on Rival Genentech (RHHBY) 3/1/2017
Troubled Cempra (CEMP) Slashes 67% of Workforce 3/1/2017
Momenta (MNTA) to Become Neighbors With Biogen (BIIB), Ironwood (IRWD) in Kendall Square Next Year 2/28/2017
A Look Inside Takeda (TKPYY)'s Remarkable R&D Transformation 2/28/2017
Bayer (BAY)'s Job Cuts at Mission Bay Campus Leaves Room for New Bay Area Startups 2/28/2017
CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston 2/28/2017
Biotech Vets Launch Arrakis Therapeutics With $38 Million and Will be Helmed By Biogen (BIIB) Alum Michael Gilman 2/28/2017
Ohr Pharma (OHRP) Suspends Work at San Diego Lab 2/27/2017
Buyers Remorse: Merck & Co. (MRK) Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix (IDIX) Buy 2/27/2017
6 Biotechs Set Up Shop and Create Jobs in Buffalo, New York 2/27/2017
Surprising Departure: Celgene (CELG) President and COO "Retiring" in the Summer 2/27/2017
50+ Valeant (VRX) Sales Reps May Have Jumped Ship to Synergy Pharma (SGYP) 2/24/2017
Backed by Johnson & Johnson (JNJ), Fusion Pharma Launches With $25 Million 2/24/2017
The End of the Road: New Jersey's NovaDel Pharma (NVD) to Dissolve 2/24/2017
North Korean Biotech Institute Allegedly Involved in the Killing of Leader Kim Jong-Un's Half Brother 2/23/2017
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/23/2017
Why This UC Berkeley Scientist is Planning to Take on Washington in 2018 2/22/2017
Pfizer (PFE), Celgene (CELG), Eli Lilly (LLY), Merck & Co. (MRK) CEOs and Other Execs Send Letter Supporting GOP Tax Plan 2/22/2017
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017
Meet the Professor Who Was the First to Question Theranos' Research 2/21/2017
Zoning Changes Kills Sale of Bristol-Myers Squibb (BMY)'s Connecticut Campus 2/21/2017
What This Contender for FDA's Top Job Could Do His First 6 Months on the Gig 2/21/2017
Why Startup Cue BioPharma Picked Daniel Passeri as Its New CEO 2/21/2017
Norwegian Biotech Upstart Has Become a Potential Takeover Target 2/21/2017
How Much Money Embattled Theranos Has Left in the Bank 2/21/2017
Swiss Biotech Santhera (SANN.SW) Opens Up 20 Employee Shop in Massachusetts, Has Plans to Grow 2/20/2017
Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics 2/20/2017
3 Biotechs With the Biggest and Most Promising Pipelines 2/20/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial 2/20/2017
Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech 2/20/2017
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa 2/17/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients 2/16/2017
Bristol-Myers Squibb (BMY) May Be on the Market, But Pfizer (PFE) Probably Won't Bite 2/16/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study 2/16/2017
Questions Remain Over Suicide Death of Genentech (RHHBY) Lobbyist 2/16/2017
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY) 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
First Ariad (ARIA), Now Senator Bernie Sanders Puts This Drug Company on Notice 2/16/2017
Ipsen (IPN.PA) Agrees to Hire 100 Merrimack (MACK) Employees Under $575 Million Cancer Deal 2/15/2017
Former Celgene (CELG) and Medtronic (MDT) CEOs Just Acquired This Maryland Biotech 2/15/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business 2/15/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force 2/15/2017
Struggling Teva (TEVA) Mulls Over Sale, Spinoff of Branded Generics Biz 2/14/2017
Eli Lilly (LLY) Quells Rumors Regarding Multi-Million Irish Expansion Plan 2/14/2017
Oops, They Did it Again: Theranos Failed to Inform Patients of Potentially Botched Diabetes Test 2/14/2017
Why Immunomedics (IMMU)' $2 Billion Deal With Seattle Genetics (SGEN) Has venBio Ticked Off and Red-Faced 2/13/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal 2/13/2017
Why Intercept Pharma (ICPT) Stock Jumped Nearly 10% On Friday After Providing Phase III Update 2/13/2017
Acorda (ACOR) Rockets After Parkinson's Drug Hits Late-Stage Goals 2/10/2017
Tom Price Confirmed as Donald Trump's Health Chief, But Stock Deals Still Raise Questions 2/10/2017
Aurobindo (AUROPHARMA.BO) Eyes U.S. Plant in New Jersey As Trump Calls for Local Drug Production 2/10/2017
New Alewife Research Center to Attract Spillover Demand From Biotechs Unable to Find Space in Kendall Square 2/10/2017
Biotech Director at Cambridge's Merrimack (MACK) Arrested for Insider Trading Scheme 2/10/2017
This 20-Employee Kendall Square Biotech Just Secured a Seat on Elon Musk's Upcoming Space Rocket 2/10/2017
This Could be Biogen (BIIB)'s Next $1 Billion Blockbuster 2/10/2017
Reckitt Benckiser (RB.L) to Lay Off 140 Employees in Missouri 2/9/2017
Pfizer (PFE) to Kiss Its Adelaide Operations Goodbye in 2021, Putting 89 Jobs on the Line 2/9/2017
Sinking Teva (TEVA) Needs a New CEO But May Need to Up Salary 2/9/2017
H. Lundbeck A/S (LUN.CO) Throws in the Towel on Alzheimer's Pill, Giving Leeway to Rival Axovant (AXON) 2/8/2017
LabCorp (LH) Makes $8 Billion+ Proposal to CRO PPD (PPDI) 2/8/2017
Eli Lilly (LLY) Seeks "Voluntary Exits" From 200 Researchers 2/8/2017
Teva (TEVA) CEO Abruptly Steps Down, Ex-Celgene (CELG) Boss Named Chairman of the Board 2/8/2017
Biotech Execs are Hoping Trump Will Pick This Man to Head the FDA 2/7/2017
No Looking Back: Cellectis (CLLS) Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial 2/7/2017
GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected 2/7/2017
GlaxoSmithKline (GSK)'s Incoming CEO Preps for Deals, R&D Decisions on New Drugs 2/7/2017
A Look at the Types of Jobs Amgen (AMGN)'s Promise to Trump Will Bring 2/7/2017
31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant (AXON) 2/6/2017
This Can Be Patheon (PTHN)'s Fate in Trump's Call for Increased Drug Production 2/6/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall 2/3/2017
Amgen (AMGN) CEO Tells Trump the Company Plans to Hire 1,600 Employees This Year 2/3/2017
What Went Down in Trump's Meeting With Biotech Execs From Amgen (AMGN), Celgene (CELG) and Merck & Co. (MRK) 2/3/2017
Pfizer (PFE) Turns to JPMorgan to Explore $2 Billion Sale of Certain Assets 2/3/2017
Eli Lilly (LLY) Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab 2/2/2017
AstraZeneca PLC (AZN) Investors Nervous as Its Recovery Hinges on the Success of New Meds and Key Drug Data 2/2/2017
Vividion Therapeutics Launches With $50 Million and a Celgene (CELG) Alum as Executive Chairman 2/2/2017
Bay Area's Galena Biopharma  (GALE) CEO Steps Down, Effective Immediately 2/2/2017
Bay Area Biotech Employees May Soon Get a New Perk—Affordable Housing 2/1/2017
Meet This Largely Over-Looked Phase 3 Alzheimer's Company 2/1/2017
Cambridge's Dimension Therapeutics (DMTX) Tanks to a New Low After Revealing Interim Hemophilia B Data 2/1/2017
Trump to Have Face-to-Face Meeting With Novartis AG (NVS) CEO, Other Pharma Bosses Today 1/31/2017
Bay Area Biotech CEOs React to Trump's Travel Ban 1/31/2017
How Trump's Immigration Ban is Already Hurting Science 1/31/2017
Bay Area's Calithera Biosciences (CALA) Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte (INCY) 1/31/2017
How Bristol-Myers Squibb (BMY) Went From Potential Mega-Acquirer to Vulnerable Mega-Target 1/31/2017
This Pharma Giant Just Revealed 7 Years of Its U.S. Drug Price Increase History 1/30/2017
FDA Lashes Out at Jazz Pharma (JAZZ) CMO for Continued Regulatory Violations 1/30/2017
These 2 New Drugs Make Celgene (CELG) an Even Bigger Biotech Powerhouse 1/30/2017
Cambridge Biotech Jounce (JNCE) Bounces on the IPO Scene, Raises $102 Million 1/27/2017
Incyte (INCY) Who? Why This Biotech Would Give Gilead (GILD) a Bang for Its Buck 1/27/2017
How Trump's Federal Hiring Freeze Impacts Biotech and an Already Short-Staffed FDA 1/27/2017
Investment Firm Pumps $800 Million Into Google (GOOG)'s Verily 1/26/2017
Endo International (ENDP) Eliminates 90 Jobs in Restructuring 1/26/2017
Booming Illumina (ILMN) Expands With a Spanking New Building in San Diego, Hiring More Than 100 1/26/2017
The Rise and Fall of Cambridge Biotech Startup Gen9 1/26/2017
Why Pfizer (PFE) Could be Johnson & Johnson (JNJ)'s Biggest Headache in 2017 1/25/2017
New Frontrunner Emerges for Top FDA Job 1/25/2017
Women Scientists Call on President Trump in Open Letter 1/25/2017
Trump's Controversial Education Nominee Betsy DeVos Also Linked to Theranos 1/24/2017
Two Former AllCells Employees Allegedly Took Confidential Info to Launch Cepheus Biosciences 1/24/2017
485 Eli Lilly (LLY) Employees Will be Out of Work Beginning March 31 1/23/2017
Earnings Preview: Here's a Look at What to Expect From 7 Biopharmas 1/23/2017
Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech 1/20/2017
Merck & Co. (MRK) Expands Discovery to New South San Francisco Facility in Heart of Bay Area and Looks to Hire 100 Employees 1/20/2017
Struggling MannKind (MNKD)'s New Strategy Includes Doubling Its Sales Force 1/19/2017
Sanofi (SNY) Exec Jumps Ship to Helm Merrimack (MACK) 1/19/2017
Theranos Shuts Down Last Remaining Blood-Testing Lab After Another Failed Inspection 1/19/2017
Embattled Theranos Forms New Advisory Board of Biotech Experts 1/18/2017
ImmunoGen (IMGN) CEO Sees Potential in Company’s Lead ADC Product 1/18/2017
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda (TKPYY) 1/18/2017
Why Bristol-Myers Squibb (BMY) Could be a Takeover Target Soon 1/18/2017
Why the Government Should Pay $156 Billion to Own Gilead (GILD) 1/18/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome 1/18/2017
Silicon Valley Exec Meets Trump for FDA Job 1/17/2017
NantKwest CEO (AKA World's Richest Doctor) Rumored to Have Met Trump for Top NIH Job 1/17/2017
Struggling OvaScience (OVAS) Offers CFO Cash to Stay on Board 1/17/2017
MiMedx CEO Allegedly Demanded Employees Donate Cash to Support GOP Candidates Like Tom Price 1/17/2017
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse 1/16/2017



//-->